Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06154902
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-04
First Post:
2023-11-27
Brief Title:
Real-World Outcomes in RelapsedRefractory Multiple Myeloma Patients Treated or Eligible for Treatment With Idecabtagene Vicleucel
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma |
Keywords: